Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001654954-24-015945
Filing Date
2024-12-27
Accepted
2024-12-27 17:05:48
Documents
11

Document Format Files

Seq Description Document Type Size
1 424B5 cvm_424b5.htm 424B5 439495
2 cvm_424b5img21.jpg GRAPHIC 66683
3 cvm_424b5img20.jpg GRAPHIC 60677
4 cvm_424b5img19.jpg GRAPHIC 63870
5 cvm_424b5img18.jpg GRAPHIC 79356
6 cvm_424b5img17.jpg GRAPHIC 61314
7 cvm_424b5img16.jpg GRAPHIC 42038
8 cvm_424b5img15.jpg GRAPHIC 48904
9 cvm_424b5img14.jpg GRAPHIC 47423
10 cvm_424b5img10.jpg GRAPHIC 6500
11 cvm_424b5img1.jpg GRAPHIC 4567
  Complete submission text file 0001654954-24-015945.txt   1104553
Mailing Address 8229 BOONE BLVD. SUITE 802 VIENNA VA 22182
Business Address 8229 BOONE BLVD . SUITE 802 VIENNA VA 22182 7035069460
CEL SCI CORP (Filer) CIK: 0000725363 (see all company filings)

EIN.: 840916344 | State of Incorp.: CO | Fiscal Year End: 0930
Type: 424B5 | Act: 33 | File No.: 333-265995 | Film No.: 241586262
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)